Supernus Pharmaceuticals, Inc.

Grantham, Mayo, Van Otterloo & Co. LLC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

4,241

Value ($000)

211

Weight

0.0%

2020 Q3 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	211	0.0%	4,241	12/31/2025
2020 Q4	2/12/2021	551	0.0%	21,900	12/31/2020
2020 Q3	11/13/2020	208	0.0%	10,000	9/30/2020